UG:NSD-United-Guardian Inc (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 13.6

Change

-0.29 (-2.09)%

Market Cap

USD 0.06B

Volume

9.58K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
IPAR Inter Parfums Inc

-0.92 (-0.74%)

USD 3.88B
NWL Newell Brands Inc

-0.02 (-0.22%)

USD 3.13B
HELE Helen of Troy Ltd

-1.37 (-2.09%)

USD 1.48B
EWCZ European Wax Center Inc

-0.05 (-0.69%)

USD 0.43B
WALD Waldencast Acquisition Corp

-0.16 (-4.05%)

USD 0.42B
WALDW Waldencast Acquisition Corp

-0.01 (-7.95%)

USD 0.37B
HNST Honest Company Inc

-0.05 (-1.27%)

USD 0.36B
DSY Big Tree Cloud Holdings Limite..

-0.30 (-8.11%)

USD 0.24B
SKIN Beauty Health Co

-0.02 (-1.12%)

USD 0.21B
RAY Raytech Holding Limited Ordina..

+0.04 (+2.86%)

USD 0.03B

ETFs Containing UG

RIE-U:CA 0.00 % 0.00 %

N/A

N/A
C061:F 0.00 % 0.00 %

N/A

N/A
F750:F 0.00 % 0.00 %

N/A

N/A
SMLU:F 0.00 % 0.00 %

N/A

N/A
C061:XETRA 0.00 % 0.00 %

N/A

N/A
F750:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 88.89% 91% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 88.89% 91% A- 80% B-
Trailing 12 Months  
Capital Gain 132.88% 82% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 132.88% 82% B 80% B-
Trailing 5 Years  
Capital Gain -30.68% 100% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.68% 100% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain -6.68% 73% C 26% F
Dividend Return -1.86% 82% B 31% F
Total Return 4.82% 100% F 84% B
Risk Return Profile  
Volatility (Standard Deviation) 36.51% 45% F 51% F
Risk Adjusted Return -5.10% 82% B 32% F
Market Capitalization 0.06B 36% F 31% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.